Depo-Provera & brain tumors

Where this case stands

1. Now

   Law firms are actively signing and filing new cases right now — this is typically when review is most available.

2. Timing

   First trials set for late 2026 — early filers are being intake-reviewed now.

3. Next

   Check the criteria below. If they may fit, a firm handling this litigation can review your situation — free, and on your schedule.

What this case is about

Plaintiffs allege Pfizer knew for decades that repeated Depo-Provera injections raise the risk of meningioma — a tumor of the lining around the brain and spinal cord — and failed to warn U.S. patients until the FDA required a new label in 2026.

Cases describe allegations that the defendants deny. Facts are drawn from public court records, settlement administrators, and litigation trackers, and can change as the case moves.

What a review will look at

• Records or pharmacy history showing your Depo-Provera injections
• The MRI/CT report or pathology confirming the meningioma
• Roughly when you started the shots and when the tumor was found

Missing records aren’t a dealbreaker — legal teams help people gather them all the time.